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Abstract
Problem/Condition: Assisted Reproductive Technology (ART) includes fertility treatments in which both eggs and sperm 
are handled in the laboratory (i.e., in vitro fertilization and related procedures).Patients who undergo ART procedures 
are more likely to deliver multiple-birth infants than women who conceive naturally. Multiple births are associated with 
increased risk for mothers and infants (e.g., pregnancy complications, premature delivery, low-birthweight infants, and 
long-term disability among infants). This report presents the most recent national data and state-specific results.
Reporting Period Covered: 2006.
Description of System: In 1996, CDC initiated data collection regarding ART procedures performed in the United 
States, as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102-
493 [October 24, 1992]). Beginning with 2004, CDC has contracted with Westat, Inc., a statistical survey research 
organization, to obtain data from ART medical centers in the United States. Westat, Inc., maintains the National ART 
Surveillance System (NASS), CDC’s web-based data collection system.
Results: In 2006, a total of 138,198 ART procedures were reported to CDC. These procedures resulted in 41,343 live-
birth deliveries, and 54,656 infants. ART procedures are categorized into four major procedure types: procedures that 
used embryos from freshly fertilized eggs (fresh embryos) from the patient’s eggs (72%); procedures that used thawed 
embryos from the patient’s eggs (16%); procedures that used fresh embryos from donor eggs (8%); and procedures that 
used thawed embryos from donor eggs (4%). Overall, 44% of ART transfer procedures resulted in a pregnancy, and 
36% in a live-birth delivery (delivery of one or more live-born infants). Live-birth rates were generally higher among 
ART procedures that used fresh embryos from donor eggs (54%) than among other types. The highest numbers of 
ART procedures were performed among residents of California (18,886); New York (13,259); Illinois (9,594); New 
Jersey (9,237); and Massachusetts (8,305). All five states reported the highest number of live-birth deliveries as a result 
of ART. Of 54,656 infants born through ART, 48% were multiple-birth deliveries. The risk for a multiple-birth deliv-
ery was highest for women who underwent ART transfer procedures that used fresh embryos from either donor eggs 
(39%) or their own eggs (31%). Approximately 1% of U.S. infants born in 2006 were conceived through ART. Those 
infants accounted for 18% of multiple births nationwide. Approximately 9% of ART singletons, 57% of ART twins, 
and 96% of ART triplets or higher-order multiples were low birthweight. Similarly, 14% of ART singletons, 65% of 
ART twins, and 97% of ART triplets or higher-order multiples were born preterm.
Interpretation: Whether an ART procedure resulted in a pregnancy and live-birth delivery varied, according to dif-
ferent patient and treatment factors. ART poses a major risk for multiple births associated with adverse maternal and 
infant outcomes (e.g., placenta previa, preterm delivery, cesarean delivery, low birthweight, and infant mortality). This 
risk varied according to the patient’s age, the type of ART procedure performed, the number of embryos available for 
transfer to the uterus, the number transferred, and the day of transfer (day 3 or 5).
Public Health Actions: ART-related multiple births 
represent a sizable proportion of all multiple births 
nationwide and in selected states. To minimize the 
adverse maternal and child health effects associated with 
multiple pregnancies, ongoing efforts to limit the number 
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of embryos transferred in each ART procedure should be continued and strengthened. Adverse maternal and infant 
outcomes (e.g., low birthweight and preterm delivery) associated with ART treatment choices should be explained 
thoroughly when counseling patients considering ART.
Introduction
Since 1978, assisted reproductive technology (ART) proce-
dures have been used to overcome infertility. The procedures 
include those infertility treatments in which both eggs and 
sperm are handled in the laboratory to establish a pregnancy 
(i.e., in vitro fertilization [IVF] and related procedures). 
Since the birth of the first U.S. infant conceived with ART 
in 1981, use of these treatments has increased dramatically. 
The number of medical centers providing ART services and 
procedures performed annually in the United States have 
steadily increased (1).
In 1992, Congress passed the Fertility Clinic Success Rate 
and Certification Act (FCSRCA),* which requires each medi-
cal center in the United States that performs ART procedures 
to report data to CDC annually on every ART procedure 
initiated. CDC uses the data to report medical center specific 
pregnancy success rates. In 1997, CDC published the first 
annual ART Success Rates Report under this mandate (2). The 
report was based on ART procedures performed in 1995. Since 
then, CDC has continued to publish the ART Success Rates 
Report annually. The report contains a national summary and 
details each medical center’s success rates. CDC also has used 
this surveillance data file to perform more in-depth analyses of 
infant outcomes (e.g., multiple births) (3–10). Multiple-infant 
births are associated with greater health problems for moth-
ers and infants, including higher rates of caesarean deliveries, 
prematurity, low birthweight, and infant death and disability 
(11,12). In the United States, ART has been associated with 
a substantial risk for multiple gestation pregnancy and mul-
tiple birth (3–10). In addition to the multiple-birth risks, 
certain studies suggest an increased risk for low birthweight 
among singleton infants conceived through ART (13,14). This 
report is based on ART surveillance data provided to CDC’s 
National Center for Chronic Disease Prevention and Health 
Promotion, Division of Reproductive Health, regarding pro-
cedures performed in 2006. A report of these data, according 
to the medical center where the procedure was performed, was 
published separately (1). In this report, emphasis is placed on 
presenting state-specific and more detailed data regarding risks 
associated with ART (e.g., multiple birth, low birthweight, 
and preterm delivery).
Methods
CDC contracted with Westat, Inc., to collect data on ART 
procedures performed in 2006 from medical centers in the 
United States and its territories. Data collected include patient 
demographics, medical history, and infertility diagnoses; 
clinical information pertaining to the ART procedure; and 
information regarding resultant pregnancies and births. The 
data file is organized with one record per ART procedure 
performed. Multiple procedures from single patients are not 
linked. Eighty-eight percent of ART medical centers reported 
their 2006 data (1). The names of nonreporting programs were 
published as prescribed by the FCSRCA.
ART data and outcomes from ART procedures are presented 
by the patient’s state of residence at time of treatment. If the 
patient’s state of residency was missing, the state of residency 
was assigned as the state where the procedure was performed. 
In addition, data regarding the number of ART procedures in 
relation to the total population for each state are indicated.† 
Data regarding number of procedures also are presented by 
procedure type and stage of procedure. ART procedures are 
classified into four types based on the source of the egg (patient 
or donor) and the status of the embryos (freshly fertilized or 
thawed): fresh embryo from the patient’s eggs or fresh embryos 
from donor eggs (fresh embryo cycles), or thawed embryos 
from the patient’s eggs, and thawed embryos from donor eggs 
(thawed embryo cycles). Because live-birth rates and multiple-
birth risk vary substantially among these four procedure 
groups, data are presented separately for each type.
Within a given procedure, different stages of treatment exist. 
A typical ART procedure begins when a woman starts taking 
drugs to stimulate egg production or her ovaries are monitored 
with the intent of transferring embryos to her uterus. If eggs are 
produced, the procedure progresses to the egg retrieval stage. 
After the eggs are retrieved, they are combined with sperm in 
the laboratory (in vitro fertilization [IVF]). If IVF is successful, 
the most viable embryos are selected for transfer. If an embryo 
implants in the uterus, a clinical pregnancy is diagnosed by 
the presence of a gestational sac detectable by ultrasound. 
Depending on the age of the mother, 13%–55% of clinical 
pregnancies are lost at a later point, mostly during the first 
12 weeks (16). Beyond 12 weeks of gestation, the pregnancy 
usually progresses to a live-birth delivery, which is defined 
* Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA), Public 
Law 102-493 (October 24, 1992).
† Data regarding population size are based on July 1, 2006, estimates from the 
U.S. Census Bureau (15).
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as the delivery of one or more live-born infants. Only ART 
procedures involving fresh embryos include an egg-retrieval 
stage. ART procedures that use thawed embryos do not include 
egg retrieval because the eggs were fertilized during a previous 
procedure, and the resulting embryos were frozen until the 
current procedure. An ART procedure can be discontinued at 
any step for medical reasons or by patient choice.
While a single measure of success is not sufficient to evalu-
ate ART efficacy, this report presents four outcome measures 
of success: pregnancy, birth of one or more live-born (the 
delivery of multiple infants is counted as one live birth), 
birth of a singleton live-born infant, and birth of two or more 
infants (multiple birth), at least one of which was live-born. 
The reported pregnancies were all diagnosed through the 
detection of a gestational sac by ultrasound. Because the ART 
surveillance system collects information on deliveries, it can 
identify deliveries in which stillborn fetuses were delivered 
together with live-born infants. A delivery of a live-born infant 
with one or more stillbirths is classified as a multiple birth, 
according to the definitions provided above. The National 
Center for Health Statistics uses similar definitions but bases 
its statistics only on the live birth records. National statistics 
classify the delivery of a single live-born infant with one or 
more stillbirths as a singleton birth.  Sensitivity analyses were 
performed on ART data excluding information on stillbirths 
and did not yield results substantially different from those 
presented in this report.
Success rates are typically computed based on all cycles ini-
tiated (per-cycles success rates), and the annual ART Success 
Rates Report emphasizes per-cycle live birth rates as the pri-
mary measures of outcome. This report presents data on all 
cycles initiated (Tables 1–2); however, most analyses are based 
on cycles in which embryos were obtained and transferred. 
This method is necessary to compare outcomes among the four 
major procedure types (thawed embryo cycles are by definition 
cycles that progressed to the transfer stage). 
In addition to the overall live-birth rate, the report presents 
a second measure of success based on the delivery of a live 
singleton. Singleton live births are a key measure of ART suc-
cess because they carry a much lower risk than multiple-infant 
births for adverse health outcomes, including prematurity, low 
birthweight, disability, and death.
This report addresses multiple birth as a separate outcome 
measure. First, each multiple-birth delivery is evaluated as a 
single event, defined as the delivery of two or more infants, 
at least one of which was live-born. The multiple-birth risk 
was calculated as the proportion of multiple-birth deliveries 
among total live-birth deliveries. In additional analyses, each 
multiple-birth infant was considered separately to compute 
the proportion of all infants born from multiple deliveries and 
the proportion of all live-born infants who were multiples.§ 
Each measure represents a different focus. The multiple-birth 
risk, which is based on the number of deliveries or infant sets, 
provides an estimate of the risk for multiple births posed by 
ART to the woman. The proportion of infants born in a mul-
tiple-birth delivery provides a measure of the impact of ART 
procedures on children in the population. The report presents 
both measures by type of ART procedure and by maternal 
age for births conceived with the patient’s eggs, and provides 
details on the multiple-birth risk by patient’s age, number of 
embryos transferred, and whether additional embryos were 
available and frozen for future use. Embryo availability (an 
indicator of embryo quality) is an independent predictor of the 
number of embryos transferred (3,6). The report also presents 
the multiple-birth risk for embryos cultured through day 3 
and day 5 by patient’s age, number of embryos transferred, 
and whether additional embryos were available and frozen for 
future use. The proportion of infants born in a multiple-birth 
delivery is presented separately by patient’s state of residency 
during ART treatment.
A typical ART procedure includes IVF of gametes, culture 
of the embryos for >2 days, and embryo transfer into the 
uterus (i.e., transcervical embryo transfer). However, in certain 
cases, unfertilized gametes (eggs and sperm) or zygotes (early 
embryos [i.e., a cell that results from fertilization of the egg 
by a sperm]) are transferred into the fallopian tubes within 
1–2 days of retrieval. These are known as gamete and zygote 
intrafallopian transfer (GIFT and ZIFT). Another variation 
is intracytoplasmic sperm injection (ICSI), in which IVF is 
accomplished by selection of a single sperm that is injected 
directly into the egg. This technique was developed originally 
for couples with male factor infertility but now is commonly 
used for many diagnostic groups.
This report presents data for each of the four procedure 
types: fresh embryos from the patient’s eggs, fresh embryos 
from donor eggs, thawed embryos from the patient’s eggs, 
and thawed embryos from donor eggs. In addition, it provides 
detailed data for the most common procedure type, those that 
use fresh embryos from the patient’s eggs. These procedures 
account for approximately 70% of ART procedures performed 
each year. For procedures that progressed to the embryo-
transfer stage, the report presents the percentage distribution 
of selected patient and treatment factors and the success rates 
(defined as live-birth deliveries per ART-transfer procedure), 
according to the same patient and treatment characteristics.
§ Includes only the number of infants live-born in a multiple-birth delivery. 
For example, if three infants were born in a live-birth delivery and one of the 
three infants was stillborn, the total number of live-born infants would be two. 
However, the two infants still would be counted as triplets.
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Patient factors included the age of the woman undergoing 
ART, whether she had previously given birth, the number 
of previous ART attempts, and the infertility diagnosis of 
female and male partners. The patient’s age at the time of the 
ART procedure was grouped into five age groups: age <35 
years, 35–37 years, 38–40 years, 41–42 years, and >42 years. 
Infertility diagnoses ranged from one factor in one partner to 
multiple factors in one or both partners. They include:
tubal factor — the woman’s fallopian tubes are blocked •	
or damaged, causing difficulty for the egg to be fertilized 
or for an embryo to travel to the uterus;
ovulatory dysfunction — the ovaries are not producing •	
eggs normally; dysfunctions include polycystic ovarian 
syndrome and multiple ovarian cysts;
diminished ovarian reserve — the ability of the ovary •	
to produce eggs is reduced; reasons include congenital, 
medical, or surgical causes or advanced age; 
endometriosis — involves the presence of tissue simi-•	
lar to the uterine lining in abnormal locations; this 
condition can affect egg fertilization and embryo 
implantation;
uterine factor — a structural or functional disorder of •	
the uterus that results in reduced fertility;
male factor — a low sperm count or problems with •	
sperm function that cause difficulty for a sperm to fertil-
ize an egg under normal conditions;
other causes of infertility — immunologic problems or •	
chromosomal abnormalities, cancer chemotherapy, or 
serious illnesses;
unexplained cause — no cause of infertility was detected •	
in either partner;
multiple factors, female — diagnosis of one or more •	
female cause; or
multiple factors, male and female — diagnosis of one or •	
more female cause, and male factor infertility.
Treatment factors included:
the number of days the embryo was cultured;•	
the number of embryos transferred;•	
whether the procedure was IVF-transfer only, IVF with •	
ICSI, GIFT, ZIFT, or a combination of IVF with or 
without ICSI and either GIFT or ZIFT;
whether extra embryos were available and frozen; and•	
whether a gestational carrier (i.e., surrogate) received the •	
transferred embryos with the expectation of gestating 
the pregnancy.
The number of embryos transferred in an ART procedure 
was categorized as 1, 2, 3, 4, or >5. The number of days of 
embryo culture was calculated using dates of egg retrieval and 
embryo transfer and was categorized as 1, 2, 3, 4, 5, 6 or ≥7. 
Because of limited sample sizes, live-birth rates are presented 
only for the two most common days, day 3 and day 5. For 
the same reason, live-birth rates are presented for IVF with 
and without ICSI and not for GIFT and ZIFT. ICSI was 
subdivided as to whether it was used among couples receiving 
a diagnosis involving male factor (the original indication for 
ICSI treatment) or not.
Chi-square tests evaluated the significance of differences in 
live-birth rates by select patient and treatment factors within 
each age group. Multivariable logistic regression models 
evaluated the independent effects of patient factors (diagnosis, 
number of previous ART procedures, and number of previ-
ous births) influencing the chances of having a live birth as a 
result of an ART procedure. Because patient age is a strong 
predictor for live birth, separate models were constructed for 
each age group. Those models provide an indication of the 
variability in live-birth rates based on patient factors separately 
for each age category. For these analyses, the referent groups 
included patients with a tubal factor diagnosis, no previous 
ART procedures, and no previous births. Multivariable models 
did not include treatment factors because of multicollinearity 
between certain treatment factors and multiple potential effect 
modifications. Detailed stratified analyses were performed to 
elucidate additional details related to associations among dif-
ferent treatment factors and the live-birth rate.
Additional analyses evaluated the impact of ART proce-
dures on total births in the United States in 2006. Because 
the goal of the analysis was to assess the effect of ART on the 
2006 U.S. birth cohort and the ART surveillance system is 
organized according to the date of the ART procedure rather 
than the infant’s date of birth, these analyses employed data 
drawn from two different ART reporting years. They covered: 
1) infants conceived from ART procedures performed in 2005 
and born in 2006 (approximately two thirds of the live-birth 
deliveries reported to the ART surveillance system for 2006); 
and 2) infants conceived from ART procedures performed in 
2006 and born in 2006 (approximately one third of the live-
birth deliveries reported to the ART surveillance system for 
2006). The U.S. natality files from CDC’s National Center 
for Heath Statistics provided data on the total number of live 
births and multiple births registered in the United States in 
2006 (17). The report presents the results of these analyses by 
plurality of birth.
Additional analyses addressed adverse infant health out-
comes, including low birthweight, very low birthweight, 
and preterm delivery. Because ART providers do not provide 
continued prenatal care after a pregnancy is established, birth-
weight and date of birth were collected via active follow-up 
with ART patients (85%) or their obstetric providers (15%). 
Although ART clinic staff collects limited information on 
infant outcomes, maternal health outcomes are not investigated 
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systematically. Low birthweight and very low birthweight were 
defined as <2,500 grams and <1,500 grams, respectively. The 
exact gestational age was estimated as date of birth minus 
date of egg retrieval (and fertilization). If the date of retrieval 
was missing, and for procedures that used thawed embryos, 
gestational age was estimated as date of birth minus date of 
embryo transfer. For comparability with the general popula-
tion, where gestational age is based on the date of the last 
menstrual period (LMP), the exact gestational age estimate 
was adjusted by adding 14 days. Preterm delivery was defined 
as gestational age <37 weeks. Preterm low birthweight was 
defined as gestational age <37 weeks and birthweight <2,500 
grams. Term low birthweight was defined as gestational age 
>37 weeks and birthweight <2,500 grams. The rates for low 
birthweight, very low birthweight, preterm, preterm low birth-
weight, preterm very low birthweight, term low birthweight, 
and term very low birthweight among ART infants born in 
2006 are presented by plurality of birth. In addition, data for 
each of the seven outcomes are presented for ART singletons 
born in 2006 by type of procedure. For the most common 
procedure type, those using fresh embryos from the patient’s 
eggs, the rates for each outcome also are presented according 
to maternal age and number of previous live births. Chi-square 
tests evaluated the significance of differences in these five out-
comes by type of ART procedure, maternal age, and number 
of previous births. All analyses were performed using the SAS® 
software system (18).
Results
Of 483 medical centers in the United States and surrounding 
territories that performed ART procedures in 2006, a total of 
426 (88%) provided data to CDC (Figure 1). The majority of 
medical centers that performed ART procedures were in the 
eastern United States, in or near major cities. The number of 
medical centers performing ART procedures varied by state. 
States with the largest number of ART medical centers report-
ing data for 2006 were California (63), New York (34), Texas 
(30), Illinois (28), Florida (27), and New Jersey (22). Two states 
(Montana and Wyoming) and three U.S. territories (Guam, the 
Federated States of Micronesia, and the U.S. Virgin Islands) 
had no ART medical centers performing ART procedures.
number and Type of ART Procedures
In 2006, a total of 138,198 ART procedures were reported 
to CDC (Table 1). This number excludes 69 ART procedures 
(<0.05%) performed in 2006 that involved the evaluation 
of a new treatment procedure. The largest number of ART 
procedures occurred among patients who used their own 
fresh embryos (99,199 [72%]). Of the 138,198 procedures 
started, 115,875 (84%) progressed to embryo transfer. Overall, 
44% of ART procedures that progressed to the transfer stage 
resulted in a pregnancy, 36% in a live-birth delivery; 25% in 
a singleton live birth, and 11% in a multiple birth live birth. 
Pregnancy and live-birth rates varied according to type of ART. 
ART procedures that used donor eggs and fresh embryos had 
the highest success rates (63% pregnancy rate, 54% live-birth 
rate, and 33% singleton live-birth rate), but also the highest 
multiple delivery rate (21%). Procedures using the patient’s 
eggs from thawed embryos had the lowest (37% pregnancy 
rate, 29% live-birth rate, 22% singleton live-birth rate, and 
7.0 % multiple live-birth rate).
The 41,343 live-birth deliveries from ART procedures per-
formed in 2006 resulted in 54,656 infants (Table 1). The num-
ber of infants born was higher than the number of live-birth 
deliveries because of multiple-infant births. ART contributed 
to the birth of 28,689 singleton infants. The largest proportion 
of infants born (37,610 or 69%) resulted from ART procedures 
in which patients used fresh embryos from their own eggs. A 
total of 9,770 infants were born from ART procedures using 
fresh and thawed donor eggs. This corresponds to 18% of all 
infants born in 2006.
The two states that had the most ART medical centers 
(California and New York) also had the highest numbers of 
ART procedures performed (Table 2). The largest numbers 
of ART procedures performed in 2006 were among residents 
of California (18,886), New York (13,259), Illinois (9,594), 
New Jersey (9,237), and Massachusetts (8,305). The five states 
with the largest number of ART procedures performed also 
ranked highest for numbers of live-birth deliveries as a result 
of ART. ART procedures were performed for residents of 
certain states and territories without an ART medical center 
(Montana, Guam, Federated States of Micronesia, U.S. Virgin 
Islands, and Wyoming). However, each accounted for a limited 
percentage (<0.1%) of total ART usage in the United States. 
Non-U.S. residents accounted for 1% of ART procedures, 
live-birth deliveries, and infants born. 
The number of ART procedures per million population 
ranged from 68 in Puerto Rico to 1,291 in Massachusetts, 
with an overall average of 463 ART procedures started per 
million persons. In addition, the number of ART procedures 
performed per million women in the reproductive age group 
(15–44 years) is reported in each state. This ratio approximates 
the proportion of women of reproductive age who used ART 
in each state. However, some women who used ART might fall 
outside the age range of 15–44 years, and some women might 
have had more than one procedure during 2006. The number 
of ART procedures per million women in the reproductive age 
group (15–44 years) varied from 314 in Puerto Rico to 6,080 
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in Massachusetts, with an overall average of 2,198 per million 
women in that age group. The two ratios, the number of ART 
procedures per million population and the number of ART 
procedures per million women in reproductive age group, were 
highly correlated (Spearman’s rank correlation = 0.99).
Characteristics of Patients and 
ART Treatments Among Women 
Who Used Fresh Embryos from 
Their own Eggs
Forty-five percent of ART transfer procedures that used fresh 
embryos from the patient’s eggs were performed on women 
aged <35 years, 24% on those aged 35–37 years, 19% on those 
aged 38–40 years, 8% on those aged 41–42 years, and 4% on 
women aged >42 years. Patient and treatment characteristics 
of these women varied by age (Table 3). Tubal factor and male 
factor infertility were reported more commonly among women 
aged <40 years who underwent ART procedures compared 
with women aged >40 years. In contrast, among women who 
underwent ART, diminished ovarian reserve, was reported for 
only 2% of women aged <35 years, for 22% of women aged 
41–42 years, and 32% of women aged >42 years. Unexplained 
infertility was reported in 7%–14% of women who underwent 
ART transfer procedures, multiple female factors in 9%–16%, 
and both male and female factors in 18%–19%.
Approximately 66% of ART procedures among women aged 
<35 years were reported as the first for that patient. Only 42% 
of procedures among women aged >42 years were reported as 
the first procedure for that patient. The percentage of ART 
procedures among women who had undergone at least one 
previous procedure increased with age. The percentage of 
procedures performed in a woman who had had a previous 
birth¶ also increased with age, from 22% in women aged <35 
years to 37% in the oldest age group.
The majority of ART procedures used IVF, and <1% used 
GIFT or ZIFT. Use of ICSI was common among couples with 
or without a diagnosis of male factor infertility, and varied by 
patient age. Despite variation among all age groups, the total 
proportion of procedures using ICSI was greater than the 
proportion of IVF without ICSI. The majority of procedures 
included embryo culture for three days; the next most com-
mon procedure involved embryo culture to day 5. Culture to 
day 5 often coincides with development of the embryo to the 
blastocyst stage. This technique was performed more frequently 
among younger women, possibly because ART procedures 
performed in younger women yielded more embryos that can 
survive in culture through day 5.
Most ART procedures involved transfer of more than one 
embryo. Among women aged <35 years, 91% of procedures 
involved the transfer of two or more embryos, and 29% 
involved transfer of three or more. For women aged >42 years, 
80% involved transfer of two or more embryos, and 60% 
involved transfer of three or more. The availability of extra 
embryos (an indicator of overall embryo quality) decreased 
sharply with age. Extra embryos were available and frozen for 
46% of procedures among women aged <35 years; 5% of pro-
cedures among women aged >42 years yielded extra embryos 
that were frozen. Data were unavailable for extra embryos that 
were not frozen for future use. Overall, 1% of ART transfer 
procedures used a gestational carrier (i.e., surrogate).
Live-Birth Rates Among Women 
Who Used Fresh Embryos from 
Their own Eggs
Live-birth rates for women who underwent ART procedures 
that used fresh embryos from their own eggs also varied by 
patient age and selected patient and treatment factors (Table 
4). Although the average live-birth rate was 35%, it sharply 
declined with age, from 45% among women aged <35 years 
to 7% among women aged >42 years. Success rates varied 
significantly across diagnostic categories among all age groups, 
except in women aged >42 years. Live-birth rates were higher 
than the age-specific average rate for several diagnostic factors. 
For example, among women aged <35 years who underwent 
ART, live-birth rates were higher for those whose diagnosis was 
ovulatory dysfunction or male factor infertility compared to the 
age-specific average. Live-birth rates were also higher than the 
age-specific average rate among women aged >42 years with an 
infertility diagnosis of uterine or male factor, or unexplained 
causes. Live-birth rates were lower than average for procedures 
among women aged >42 years with an infertility diagnosis of 
tubal factor, ovulatory dysfunction, endometriosis, multiple 
factors, female only or other causes. Live-birth rates were higher 
for procedures in women aged <42 years who had undergone 
no previous ART procedures, but this difference was statisti-
cally significant only for procedures in women aged <40 years. 
Live-birth rates were higher for procedures in women who had 
one or more previous births than for procedures in women with 
no previous births. However, this difference was not statistically 
significant for procedures in women aged >42 years.
Live-births were rated higher for ART procedures that used 
IVF-ET without ICSI, in comparison with procedures that 
used ICSI, regardless of whether male factor infertility was 
reported, except in women aged >42 who were diagnosed with 
¶ Data were not available to distinguish whether previous births were conceived 
naturally, with ART, or other infertility treatments.
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male factor (Table 4). In all age groups, live-birth rates were 
lowest for procedures in couples who used ICSI in the absence 
of male factor infertility. These differences were statistically 
significant for women in all age groups with the exception of 
women aged 41–42 years.
In all age groups, live-birth rates were higher than average 
for procedures among women who had extended embryo 
culture to day 5, transferred two or more embryos, and had 
extra embryos available and frozen for future use. Variations 
in live-birth rates were statistically significant for these treat-
ment factors within all age groups, with the exception of the 
number of days of embryo culture among women aged >42 
years. Live-birth rates increased in all age groups when a gesta-
tional carrier was used. However, these results did not achieve 
statistical significance in any age group. 
The use of ICSI in the absence of male factor infertility in 
women considered difficult to treat was evaluated separately. 
These groups included women who underwent previous ART 
cycles but had no previous pregnancies or births, women 
diagnosed with diminished ovarian reserve, and ones with 
fewer than five eggs retrieved. Within each of these groups, 
age-specific–live-birth rates for IVF-ET with and without 
ICSI were examined. In all but four cases, women who used 
IVF with ICSI had lower live-birth rates than women who 
used IVF without ICSI. The four exceptions were: 1) women 
aged <35 years who had previous ART cycles but no previ-
ous pregnancies or births; 2) women aged >42 years who had 
previous ART cycles but  no previous pregnancies or births; 3) 
women aged 41–42 years with fewer than five eggs retrieved; 
and 4) women aged 41–42 years with diminished ovarian 
reserve. However, in all other cases, the pattern of these results 
is consistent with the findings presented in this report (Table 
4). Additional analyses also fail to support a clear advantage 
in using ICSI when treating couples with no indication of 
male factor infertility. After adjusting for female prognosis 
factors and types of IVF procedures, cycles using ICSI with 
no indication of male-factor infertility were less likely to fail 
before transfer but more likely to result in implantation fail-
ure, pregnancy loss, and a lower overall chance of a live birth 
delivery. ICSI effects on the next cycle were slightly improved 
but not better than those without using ICSI.
Additional analyses suggest that success rates from blastocyst 
transfers could be overestimated, especially for women aged 
>40 years, because cycles terminated before a transfer are not 
considered in the evaluation, and because a large proportion of 
embryos fail to survive to day 5. Finally, the results of analyses 
stratified by patient age, number of embryos transferred, day 
of embryo transfer (day 3 or 5), and number of embryos avail-
able simultaneously are included with the discussion regarding 
multiple-birth risk.
Total live-birth rates were compared with singleton live-birth 
rates for procedures employing fresh embryos from the patient’s 
own eggs (Figure 2). Live-birth and singleton live-birth rates 
decreased with patient age. Across all age groups, singleton 
live-birth rates were lower than live-birth rates. However, the 
magnitude of the difference between both measures declined 
with patient age.
Live-Birth Rates among Women Who 
Used Fresh Donor Eggs or Thawed 
Donor Eggs or Embryos
The average live-birth delivery rate among women who 
underwent ART-transfer procedures using donor eggs was 
46.1% (Table 5). In contrast with the sharp age-dependent 
decline in live-birth rates observed for ART procedures using 
the patients’ own fresh embryos, live-birth delivery rates 
did not vary substantially with the age of the patient or the 
intended mother when donor eggs were used. In 2006, a total 
of 10,984 ART procedures were performed using fresh donor 
eggs. Of these, 10,049 ART procedures (91.5%) progressed 
to an embryo transfer. The live-birth delivery rate for women 
who used fresh donor eggs varied only slightly from 54.4% 
among women aged <35 years to 53.2% among women aged 
>42 years. The highest live-birth delivery rates of 55.2% 
occurred among women aged 38–40 years, and the lowest 
delivery rate of 52.4 % occurred among women aged 40–42. 
The total number of ART procedures performed that used 
thawed donor eggs or embryos was 5,992, of which 5,456 
ART procedures (91.1%) progressed to a transfer. Live-birth 
delivery rates were lower for procedures using thawed donor 
eggs or embryos compared to those using fresh donor eggs in 
all age groups, declining slightly with the age of the intended 
mother from 34.9% among women aged <35 years to 31.1% 
aged >42 years.
Multiple-Birth Risks Associated 
with ART
Of 12,654 multiple-birth deliveries, 8,722 (69%) were from 
pregnancies conceived with fresh embryos from the patient’s 
eggs, 1,402 (11.1%) were from thawed embryos from the 
patient’s eggs, 2,107 (16.7%) were from fresh embryos from 
a donor’s eggs, and 423 (3%) were from thawed embryos from 
a donor’s eggs (Table 6). Compared with ART procedures that 
used the patient’s eggs and fresh embryos, the risks for multiple-
birth delivery were increased when eggs from a donor were 
used and decreased when thawed embryos were used. Among 
ART procedures in which fresh embryos from the patient’s 
own eggs were used, a strong inverse relation existed between 
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multiple-birth risk and patient age. The average multiple-
birth risk for ART procedures in which fresh embryos from 
the patient’s eggs were used was 31%. The multiple-birth risk 
varied from 34% among women aged <35 years to 9% among 
those aged >42 years.
Of 54,656 infants born through ART, 48% (25,967) were 
born in multiple-birth deliveries (Table 6). The proportion of 
infants born in a multiple-birth delivery also varied by type 
of ART procedure and patient age. Among ART transfer pro-
cedures in which the patient used fresh embryos from their 
own eggs, the proportion of infants born in a multiple-birth 
delivery ranged from 52% among women aged <35 years to 
18% among women aged >42 years. Among ART transfer 
procedures in which thawed embryos from the patient’s eggs 
were used, the proportion of infants born in a multiple-birth 
delivery ranged from 42% in women aged <35 years to 32% 
aged >42 years. When thawed embryos from donor eggs were 
used, the proportion of infants born in a multiple-birth delivery 
was 40%. The proportion of infants born in a multiple-birth 
delivery was highest (57%) in women who used fresh embryos 
from donor eggs.
A more detailed examination of multiple-birth risk for 
ART procedures employing fresh embryos from the patient’s 
own eggs indicated that the number of embryos transferred 
was a key risk factor for multiple-birth delivery, but that the 
magnitude of the association varied by patient age (Table 7). 
Among all age groups, transfer of two or more embryos was 
associated with increased live-birth delivery rates. However, 
the multiple-birth risk also increased substantially. Among 
women aged <42 years, the percentage of twin deliveries and 
the percentage of triplet or higher-order deliveries increased 
with higher numbers of embryos transferred. This trend was 
not apparent for procedures in women aged >42 years among 
whom singleton births increased when more than one embryo 
was transferred. Women in these age groups have embryos with 
reduced implantation potential and therefore are less likely to 
have multiple births when multiple embryos are transferred.
Additional analyses addressed multiple-birth risk among 
patients who used fresh embryos from their own eggs and set 
aside extra embryos for future use (Table 7). These patients can 
be thought of as those with elective embryo transfer because 
they chose to transfer fewer embryos than the total number 
that were available. For procedures in women with elective 
embryo transfer who were aged <35 years, live-birth rates 
were 49% when only one embryo was transferred and 55% 
when two embryos were transferred. The higher live-birth 
rate after transfer of two embryos was associated with a large 
increase in the multiple-birth risk (38% compared with 1% 
after single embryo transfer).  For procedures in women aged 
35–37 years, live-birth rates were 41% with elective embryo 
transfer of a single embryo and 48% when two embryos were 
transferred. In the younger age category, the higher live-birth 
rate after transfer of two embryos was associated with a large 
increase in the multiple-birth risk (33% compared with 2% 
after single embryo transfer).**
Among patients who used fresh embryos from their own 
eggs, the live-birth rates and multiple-birth risks typically were 
higher for embryo transfers on day 5 than on day 3 (Table 8). 
Overall, across all age groups, fewer embryos were transferred 
on day 5 than on day 3. For example, among women aged <35 
years, two or fewer embryos were transferred in 87% of day 5 
transfers and in 62% of day 3 transfers. Similarly, in women 
aged <35 years, 93% of day 5 elective transfers and 73% of 
day 3 elective transfers involved the transfer of two or fewer 
embryos. Live-birth rates and multiple-birth risks were higher 
for patients who had elective embryo transfers. For women 
aged <35 years who had elective embryo transfer on day 5, the 
percentage of transfers resulting in live births was 53% when 
one embryo was transferred, and 59% when two embryos were 
transferred. By contrast, the multiple-birth risks in these two 
groups were 2% and 44%, respectively. Thus, the 6% higher 
live-birth rate associated with the transfer of two embryos was 
accompanied by a 42% higher risk of multiple delivery. If suc-
cess is measured in terms of singleton live-birth, the highest 
success rates for this group were with one embryo transferred. 
This also was true for women aged 35–37 years with elective 
single embryo transfers on day 5 (Table 8).
The states with the highest number of ART-associated live-
birth deliveries also had the highest number of infants born in 
multiple-birth deliveries (Table 9). These include California 
(3,553), New York (1,959), New Jersey (1,811), Texas (1,554), 
Illinois (1,505), Florida (1,225), and Massachusetts (1,212). 
Nationwide, the percentage of ART-born infants who were 
born in multiple-birth deliveries was 48%; the percentage of 
twins was 43%, triplets or higher-order multiples was 4%. The 
percentage of ART-born infants in multiple-birth deliveries 
was >50% in many states. The states with the highest propor-
tion of ART-born infants in multiple-birth deliveries were 
Wyoming (64%), Maine (62%), Arkansas (59%), New Mexico 
(57%), Oregon (55%), North Dakota (55%), Nevada (53%), 
Louisiana (53%), and Montana (51%). These findings should 
be interpreted with caution because of an overall low number 
of live births resulting from ART in certain states.
Of 4,265,555 infants born in the United States in 2006, a 
total of 52,792 (1%) were conceived with ART (Table 10). 
 ** Results are based on total multiple-birth risk and do not provide an indica-
tion of pregnancies that began as twins, triplets, or a higher order but reduced 
(either spontaneously or through medical intervention) to singletons or twins 
(Tables 6 and 7).
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Infants conceived with ART accounted for 0.7% of singleton 
births and 18% of multiple births nationwide; 17% of all twins 
and 38% of infants born in triplets or higher-order multiples 
were conceived with ART.
Perinatal Risks Associated with ART
The percentage of infants with low birthweight varied from 
9% among singletons to 96% for triplets or higher-order 
multiples. The percentages of very low birthweight, preterm, 
preterm low birthweight, and preterm very low birthweight 
displayed similar patterns (Table 11).
The percentages of ART singletons that were low birthweight 
and preterm varied by procedure type and selected maternal 
factors (Table 12). The variation in risk across procedure 
types was statistically significant for six perinatal outcomes: 
low birthweight, very low birthweight, preterm, preterm low, 
preterm very low, and term low birthweight. In comparison 
with singletons born after procedures that used fresh embryos 
derived from the patients’ eggs, singletons born after proce-
dures that used fresh embryos derived from donor eggs were at 
increased risk for five perinatal outcomes: low birthweight, very 
low birthweight, preterm delivery, preterm low birthweight, 
and preterm very low birthweight. Singletons born after pro-
cedures that used thawed embryos were at decreased risk for 
low birthweight, very low birthweight, preterm low, preterm 
very low birthweight, and term low birthweight; however, 
they were at  increased risk for preterm delivery as compared 
to singletons born after procedures that used fresh embryos 
derived from the patients’eggs. 
More detailed analysis of maternal factors among singletons 
born after procedures that used fresh embryos derived from 
the patients’ eggs indicated higher risks of low birthweight, 
very low birthweight, preterm delivery, preterm low birth-
weight, and preterm very low birth weight for women aged 
>42 years. These differences in risks were not statistically 
significant. Mothers with no previous births had a higher risk 
for low birthweight, preterm low birthweight, and term low 
birthweight than those who had one or more previous births. 
The variation in risks was statistically significant (p<0.01) for 
these three outcomes.
Discussion
According to the most recent estimates of infertility in the 
United States, 10% of women of reproductive age (15–44 
years) reported a previous infertility-associated health-care visit, 
and 2% reported a visit during the previous year (19). Among 
married couples in which the woman was of reproductive 
age, 7% reported they had not conceived after 12 months of 
unprotected intercourse. With advances in ART, couples are 
increasingly using this form of treatment to overcome their 
infertility.
Since the birth of the first infant through ART in the United 
States in 1981, use of ART has grown substantially and has 
consistently increased in the United States since 1996, when 
CDC began ART surveillance. The increased use of ART, 
coupled with higher ART success rates, has resulted in dramatic 
increases in the number of children conceived through ART 
each year. The number of ART procedures reported to CDC 
has more than doubled, from 64,681 in 1996 to 138,198 
in 2006 (1). During the same period, the number of infants 
conceived through ART procedures more than doubled, from 
20,840 to 54,656.
This report documents that in 2006, ART use varied accord-
ing to the patient’s state of residency. Residents of California, 
New York, Illinois, New Jersey, Massachusetts, Florida, and 
Texas reported the highest number of ART procedures. These 
states also reported the highest number of infants conceived 
through ART. In 2006, ART use by state of residency was 
not consistent with expectations based on the total popula-
tion within states (15). For example, Massachusetts had the 
fifth highest number of ART procedures performed, but 
ranked thirteenth in total population.†† Similarly, residents of 
District of Columbia, Rhode Island, and Hawaii underwent 
more ART procedures than would have been expected based 
on their population sizes. As a result, state-specific ratios of 
ART procedures by population varied according to state of 
residency. The highest ratios of the number of ART procedures 
among state residents per 1 million population were observed 
in Massachusetts (1, 291), District of Columbia (1,216), New 
Jersey (1,066), Connecticut (956), Maryland (835), and Illinois 
(751). This divergence was expected because in 2006, some 
of these states, including Massachusetts and New Jersey, had 
statewide mandates for insurance coverage for ART procedures. 
Variation between states also might be related to availability of 
ART services within each state. However, the relation between 
demand for services and availability is difficult to evaluate (e.g., 
increased availability in certain states might reflect the increased 
demand for ART among state residents).
Among women who used fresh embryos from their own eggs, 
patient factors (e.g., infertility diagnoses, history of previous 
ART procedures, and previous births) varied considerably by 
age. The proportion of procedures in which the couple received 
a diagnosis of ovulatory dysfunction, endometriosis, or male 
factor infertility decreased with the woman’s age, whereas the 
proportion of procedures in which the couple received a diag-
 †† Data regarding population size are based on July 1, 2006, estimates from the 
U.S. Census Bureau (15).
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nosis of diminished ovarian reserve increased with the woman’s 
age. History of previous ART cycles and previous births were 
more common among older women. In addition, treatment 
factors varied considerably by the woman’s age. The propor-
tion of procedures in which embryo transfer occurred on day 
3 increased with the age of the woman, and the proportion of 
procedures in which embryo transfer occurred on day 5 (i.e., 
the blastocyst stage) declined with the age of the woman. The 
proportion of procedures in which more than three embryos 
were transferred increased sharply with age.
Because ART success rates are affected by multiple patient 
and treatment factors, using a single measure of success is not 
sufficient to evaluate ART efficacy. At a minimum, ART pro-
cedures should be subdivided on the basis of the source of the 
egg (patient or donor) and the status of the embryos (freshly 
fertilized or thawed) because success rates vary substantially 
across these types. Within the type of ART procedure, further 
variation exists in success rates by patient and treatment factors, 
most notably patient age. Other factors to consider when assess-
ing success rates are infertility diagnosis, number of previous 
ART procedures, number of previous births, method of embryo 
fertilization and transfer, number of days of embryo culture, 
number of embryos transferred, availability of extra embryos, 
and use of a gestational carrier (i.e., surrogate). Variation exists 
in success rates according to each factor.
CDC’s primary focus in collecting ART data has been on 
live-birth deliveries as an indicator of success because ART 
surveillance activities were developed in response to a federal 
mandate to report ART success rate data. This mandate requires 
CDC to collect data from all ART medical centers and report 
success rates defined as all live births per ovarian stimulation 
procedures, or ART procedures, for each ART medical center. 
CDC’s key role has been to publish standardized data related to 
ART success rates, including information regarding factors that 
affect these rates. These data can be used to help individuals and 
couples make informed decisions regarding whether to undergo 
this time-consuming and expensive treatment (20).§§ However, 
success-rate data also should be balanced with consideration 
of effects on maternal and infant health. CDC receives data 
on pregnancy outcomes of public health significance, which 
enables it to monitor multiple-birth rates, preterm delivery, 
and low birthweight associated with ART.
Since the 1980s, multiple births have increased substantially 
in the United States (17,21). The increase in multiple births 
has been attributed to an increased use of ART and delayed 
childbearing (5,22,23). Although infants conceived with ART 
accounted for approximately 1% of the total births in the 
United States in 2006, the proportion of twins and triplets 
or higher-order multiples attributed to ART were 17% and 
38%, respectively, which is similar to rates for previous years. 
In 1999, the Society for Assisted Reproductive Technology 
(SART) and the American Society for Reproductive Medicine 
(ASRM) issued voluntary guidelines (24) on the number of 
embryos transferred. Since multiple gestations lead to an 
increased risk of complication in both the fetuses and the 
mothers, ASRM and SART have developed recommendations 
on the number of cleavage-stage (usually 2 or 3 days after 
fertilization) embryos or blastocysts (usually 5 or 6 days after 
fertilization) that should be transferred based on patient’s age 
and prognoses. These guidelines were revised in 2004 (25), 
2006 (26), and 2008 (27 ).
In certain states, ART procedures are not covered by insur-
ance carriers, and patients might feel pressured to maximize 
the opportunity for live-birth delivery by transferring multiple 
embryos. In addition, if success is defined solely as total live-
birth delivery, anecdotal evidence suggests that certain ART 
providers might feel pressure to transfer multiple embryos to 
maximize their publicly reported success rates (28). In the 
United States, transfer of more than two embryos was still 
a common practice in 2006. Approximately 43% of ART 
procedures that used fresh patients’ eggs or embryos and 
progressed to the embryo-transfer stage involved the transfer 
of three or more embryos. Approximately 16% of procedures 
involved the transfer of four or more, and 5% of procedures 
involved the transfer of five or more embryos (1). However, 
among women aged <35 years, the proportion of ART pro-
cedures that involved four or more embryos transferred was 
approximately 6% (substantially less than the average of 16% 
for all transfers) because women in this age category typically 
experience higher success rates with fewer embryos transferred. 
Certain scientific reports have advocated that singleton live-
birth rates be presented as a distinct indicator of ART success 
(29–35). This report includes this measure (Figure 2) and 
presents it with total live-birth rates. Success rates based on 
singleton live-birth deliveries will provide patients with a 
measure that more directly highlights infant outcomes with 
the optimal short- and long-term prognosis. Twins, albeit to 
a lesser extent than triplets or higher-order multiples, have 
substantially increased risks for infant morbidity and mortal-
ity (17). The risks for low birthweight and preterm birth both 
exceed 57% for twins, and the risk for very low birthweight is 
9%. In addition, because twins are at substantially increased 
risk for perinatal and infant mortality (11, 21), singleton live-
birth rates are a valid measure of success.
Data in this report indicate that 49% of infants born through 
ART in 2006 were born in multiple-birth deliveries, compared 
with 3% in the general U.S. population (17). The twin rate was 
 §§ Estimated cost for one procedure of IVF averages $12,400 (20).
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44%, compared with 3% in the general U.S. population, and 
the rate of triplets and higher-order multiples was 5%, approxi-
mately 25 times higher than the general U.S. population rate 
(0.2%). The percentage of infants born in multiple-birth 
deliveries were among the highest for women who underwent 
ART procedures that used fresh embryos from their own eggs 
(48%) or from donor eggs (57%). In 22 states, U.S. Virgin 
Islands and Puerto Rico, >50% of infants conceived through 
ART were born in multiple-birth deliveries. Multiple births 
resulting from ART are an increasing public health concern 
nationwide and for the majority of states.
The multiple-birth risk increased for women who underwent 
ART procedures using fresh embryos from their own eggs 
after multiple embryos were transferred. Embryo availability, 
an indicator of embryo quality, also was a strong predictor of 
multiple-birth risk independent from the number of embryos 
transferred. In analyses stratified by patient age, number of 
embryos transferred, day of embryo culture (day 3 or 5), and 
embryo availability, high live-birth rates and singleton live-
birth rates were achieved, particularly among younger women 
as transfer of a single embryo was efficacious. In the majority 
of groups, limiting the number of embryos transferred can 
minimize the multiple-birth risk without severely compromis-
ing the success rates.
In addition to the known multiple-birth risks associated with 
ART, singleton infants conceived from ART procedures are 
at increased risk for low birthweight and preterm delivery. In 
2006, of all singleton infants conceived with ART, 9% were low 
birthweight, compared with 6% in the general U.S. population 
(17). Approximately 2% of singleton infants conceived from 
ART were very low birthweight, compared with approximately 
1% of singletons conceived in the general U.S. population. 
The percentage of ART singletons born preterm was 13% in 
comparison to 11% for the general U.S. population. Adverse 
infant health outcomes among singletons (e.g., low birthweight 
and preterm delivery) also should be considered when assessing 
the efficacy and safety of ART.
A comparison of perinatal outcomes among ART twins and 
triplets or higher-order multiples with their counterparts in the 
general population is not useful for at least two reasons. First, 
although ART and other infertility treatments account for a 
substantial proportion of multiple births in the United States, 
distinguishing between naturally conceived multiple births 
from iatrogenic (i.e., medically assisted) multiple births is not 
possible. ART accounts for only 1% of the total U.S. births. 
However, it accounts for 17% of twins and 38% of triplets 
or higher-order multiples. Second, the majority of multiple 
births conceived after ART treatment are likely dizygotic 
from multiple embryo transfer. Among natural conceptions, 
approximately one third to one half of twins might be monozy-
gotic, depending on maternal age (36). Monozygotic twins 
are at increased risk for adverse outcomes in comparison with 
dizygotic twins (37).
Multiple births are associated with an increased health risk 
for mothers and infants (11,12,20,22). Women with multiple-
gestation pregnancies are at increased risk for maternal compli-
cations (e.g., hemorrhage and hypertension). Infants born in 
a multiple-birth delivery are at increased risk for prematurity, 
low birthweight, infant mortality, and long-term disability. The 
contribution of ART to preterm births in the United States also 
is a key concern. This report documents that approximately 
41% of ART infants born in 2006 were preterm (Table 11), 
compared with approximately 13% of preterm births in the 
general U.S. population (17). Preterm infants have increased 
risk for death and have more health and developmental prob-
lems than full-term infants (38–41). The health risks associated 
with preterm births have contributed to increasing health-care 
costs. In 2005, the economic burden associated with preterm 
births in the United States has been estimated at $26 billion 
($51,600 per infant born preterm) (41). ART infants born pre-
term accounted for approximately 4% of all preterm births in 
the United States in 2006, a total economic burden estimated 
at $1 billion. ASRM and SART guidelines on the number of 
embryos that should be transferred in an ART cycle might 
help in further reducing the incidence of preterm deliveries, 
the majority of which are multiples (24–27).
The findings in this report are subject to at least four limita-
tions. First, ART surveillance data were reported for each ART 
procedure performed rather than for each patient who used 
ART. Linking procedures among patients who underwent more 
than one ART procedure in a given year is not possible. Because 
patients who underwent more than one procedure in a given 
year were most likely to include those in which a pregnancy was 
not achieved, the success rates reported might underestimate 
the true per-patient success rate. In addition, ratios of ART 
procedures per population might be higher than the unknown 
ratio of the number of persons undergoing ART per popula-
tion. Second, these data represent couples who sought ART 
services in 2006; therefore, success rates do not represent all 
couples with infertility who were potential ART users dur-
ing that time. Third, because treatment was not randomized 
but rather based on medical center assessment and patient 
choice, results for treatment factors must be considered with 
caution. The results for treatment factors need to be carefully 
considered because treatment was not randomly assigned as is 
done in a clinical trial, but based on medical center assessment 
and patient choice. Comparisons in success rates are prone 
to confounding by patient and treatment factors. Although 
variability in live-birth rates among patients who used dif-
ferent treatment options cannot be completely adjusted for 
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determinants of treatment assignment (i.e., confounding by 
indication might remain after adjustment), stratified analyses 
were used to examine associations between treatment fac-
tors and live-birth rates among more homogenous groups of 
patients. Finally, approximately 12% of medical centers that 
performed ART in 2006 did not report their data to CDC 
as required by law, and might have had results different from 
clinics that reported their data.
ART data are reported to CDC by the ART medical center 
where the procedure was performed rather than by the state 
in which the patient resided. In this report, ART data are 
presented by the female patient’s state of residence. Residency 
data were missing for approximately 5% of all live-birth deliv-
eries resulting from ART procedures started in 2006. In cases 
of missing residency data, residency was assigned as the state 
where the ART procedure was performed. As a result, the num-
ber of procedures performed among state residents, number 
of infants, and number of multiple-birth infants might have 
been slightly overestimated for certain states. Concurrently, 
the numbers might be underestimated in states that border 
states with high rates of missing residency data, particularly 
states in the northeast. Nonetheless, the effects of missing 
residency data were not substantial. Statistics were evaluated 
separately according to the location of the ART medical center 
rather than the patient’s state of residence. The rankings of 
the ART medical center location by total number of infants 
and multiple-birth infants were similar to the rankings based 
on the patient’s state of residence, which was reported at the 
time of ART treatment. The possibility of migration during 
the interval between ART treatment and birth exists. U.S. 
Census Bureau data indicate that approximately 3% of the 
U.S. population moves between states annually. This rate is 
even higher for persons aged 20–34 years (42). Members of 
the U.S. armed forces have a high potential for migration. 
Therefore, ART procedures performed among patients who 
attended military medical centers were evaluated separately. 
In 2006, <1% of ART procedures were performed in four 
military medical centers (California, District of Columbia, 
Hawaii, and Texas). In certain facilities, a substantial number 
of distinct states were listed for patient’s state of residence. 
States and territories for which >1% of ART procedures among 
residents were performed in a military medical center were 
Alaska, Delaware, District of Columbia, Hawaii, Maryland, 
New Mexico, North Carolina, Oklahoma, Texas, Virginia, and 
Wyoming. States for which >5% of ART procedures among 
state residents were performed in a military medical center 
were District of Columbia and Hawaii. 
Despite these limitations, findings from national surveillance 
of ART procedures performed in the United States provide 
useful information for patients contemplating ART, ART 
providers, and health-care policy makers. ART surveillance 
data can be used to monitor trends in ART use and outcomes 
from ART procedures. Data from ART surveillance can be 
used to assess patient and treatment factors that contribute to 
higher success rates. Ongoing surveillance data can be used 
to assess the risk for multiple births and adverse perinatal 
outcomes among singleton births. Surveillance data provide 
information to assess changes in clinical practice related to 
ART treatment.
Increased use of ART procedures and the practice of transfer-
ring multiple embryos during ART treatments have led to high 
multiple-birth rates in the United States (5, 10). Balancing the 
chance of success of ART against the risk for multiple births 
can be a challenge. Implementation of approaches to limit 
the number of embryos transferred for patients undergoing 
ART should reduce the occurrence of multiple births resulting 
from ART. Such efforts ultimately might lead ART patients 
and providers to view treatment success in terms of singleton 
pregnancies and births. In addition, continued research is 
needed to understand the adverse effects of ART on maternal 
and child health. CDC will continue to provide updates of 
ART use in the United States as data become available.
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FIGURE 1. Location of assisted reproductive technology clinics — United States and Puerto Rico, 2006
No. clinics
PR
No. ART clinics in the United States in 2006 483
No. ART clinics that submitted data in 2006 426
No. ART cycles reported in 2006 138,198*
No. live-birth deliveries resulting from ART cycles started in 2006 41,343
No. infants born as a result of ART cycles carried out in 2006 54,656
* This number does not include 69 cycles in which a new treatment procedure was being evaluated.
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FIGURE 2. Percentage of transfers resulting in live births and 
singleton  live births for assisted reproductive technology pro-
cedures performed among women who used freshly fertilized 













































infantsNo. (%)* No. (%)* No. (%)* No. (%)*
Patient’s eggs used
Fresh embryos 99,199 87,799 80,313 34,719 43.2 28,404 35.4 19,682 24.5 8,722 10.9 37,610
Thawed embryos 22,023 NA† 20,057 7,401 36.9 5,797 28.9 4,395 21.9 1,402 7.0 7,276
Donor eggs used
Fresh embryos 10,984 10,391 10,049 6,315 62.8 5,393 53.7 3,286 32.7 2,107 21.0 7,572
Thawed embryos 5,992 NA† 5,456 2,136 39.1 1,749 32.1 1,326 24.3 423 7.8 2,198
Total 138,198§  NA† 115,875 50,571 43.6 41,343 35.7 28,689 24.8 12,654 10.9 54,656
* Number of outcomes per 100 embryo transfers
† Not applicable
§ This number does not include 69 cycles in which a new treatment procedure was being evaluated.
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TABLE 2.  Number of reported assisted reproductive technology (ART) procedures performed, number of pregnancies, number 
of live-birth  deliveries, and number of infants born, by patient’s state/territory of residence* at time of treatment — United States, 
2006
Procedures started Embryo Transfers Pregnancies 
Live-birth  




























Alabama 868 1 738 1 335 1 280 0 369 0 189.1 920.6
Alaska 189 0 147 0 69 0 55 0 73 0 279.0 1,314.9
Arizona 2,313 10 1,954 9 858 3 676 1 890 2 375.1 1,855.9
Arkansas 415 0 362 0 163 0 141 0 203 0 147.7 733.1
California 18,886 1,120 16,486 952 6,726 362 5,457 280 7,288 359 521.0 2,421.4
Colorado 1,706 7 1,499 6 903 4 756 3 1,025 3 357.9 1,697.3
Connecticut 3,341 31 2,744 28 1,228 9 1,022 8 1,303 9 955.7 4,742.7
Delaware 301 0 245 0 127 0 106 0 138 0 353.0 1,696.2
District of Columbia§ 712 3 612 3 270 0 222 0 288 0 1,216.1 4,868.3
Federated States 
 of Micronesia
¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Florida 6,389 18 5,210 17 2,280 7 1,876 4 2,505 4 353.8 1,826.6
Georgia 2,991 1,348 2,535 1,141 1,171 498 989 436 1,317 589 320.2 1,467.4
Guam ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Hawaii 570 2 455 2 177 1 145 0 198 0 445.8 2,243.4
Idaho 506 0 457 0 200 0 174 0 232 0 345.7 1,711.7
Illinois 9,594 14 7,725 13 3,122 6 2,525 6 3,297 10 750.9 3,571.6
Indiana 1,844 2 1,505 1 574 0 471 0 630 0 292.6 1,426.9
Iowa 899 0 758 0 395 0 342 0 437 0 302.4 1,535.8
Kansas 704 0 569 0 274 0 230 0 295 0 255.5 1,266.0
Kentucky 948 0 819 0 388 0 314 0 425 0 225.5 1,091.9
Louisiana 891 0 742 0 306 0 246 0 343 0 210.0 990.9
Maine 221 0 201 0 97 0 86 0 128 0 168.1 860.0
Maryland 4,677 55 3,914 49 1,699 20 1,391 16 1,798 18 834.9 3,899.4
Massachusetts 8,305 2,579 7,028 2,155 2,903 856 2,352 688 2,965 893 1290.7 6,079.7
Michigan 3,264 5 2,747 5 1,227 0 1,027 0 1,390 0 323.1 1,580.2
Minnesota 2,008 2 1,744 2 895 2 731 1 947 1 389.6 1,890.3
Mississippi 438 0 370 0 150 0 136 0 178 0 151.1 723.1
Missouri 1,842 1 1,512 1 730 1 589 1 795 1 315.5 1,542.2
Montana 176 0 156 0 90 0 81 0 109 0 185.9 972.8
Nebraska 582 0 438 0 204 0 180 0 243 0 330.0 1,642.5
Nevada 1,254 0 1,115 0 504 0 410 0 563 0 503.1 2,482.1
New Hampshire 796 0 674 0 286 0 236 0 304 0 606.8 2,989.6
New Jersey 9,237 234 7,383 179 3,346 83 2,695 68 3,622 93 1065.9 5226.2
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TABLE 2.  (Continued) Number of reported assisted reproductive technology (ART) procedures performed, number of pregnancies, 
number of live-birth  deliveries, and number of infants born, by patient’s state/territory of residence* at time of treatment — United 
States, 2006
Procedures started Embryo Transfers Pregnancies 
Live-birth  




























New Mexico 288 0 240 0 135 0 114 0 163 0 148.3 723.4
New York** 13,259 80 10,852 74 4,280 27 3,415 23 4,419 29 687.7 3,232.3
New York City 4,428 597 3,415 475 1,386 209 1,074 171 1,383 217 536.7 2,345.2
North Carolina 2,608 3 2,230 3 1,052 1 889 1 1,179 1 294.0 1,405.9
North Dakota 216 0 195 0 77 0 65 0 91 0 338.8 1,697.2
Ohio 3,344 0 2,798 0 1,237 0 1,029 0 1,373 0 291.7 1,438.4
Oklahoma 627 1 548 1 271 0 243 0 321 0 175.3 866.9
Oregon 1,148 2 1,004 2 454 1 403 1 558 1 311.0 1,551.2
Pennsylvania 4,611 476 3,749 381 1,558 174 1,280 137 1,643 183 371.8 1,881.5
Puerto Rico 266 13 232 11 90 2 67 0 95 0 67.7 313.9
Rhode Island 760 0 643 0 264 0 211 0 272 0 715.9 3,385.8
South Carolina 990 0 898 0 464 0 380 0 516 0 228.6 1,108.6
South Dakota 197 1 177 1 75 1 64 0 85 0 249.9 1,282.8
Tennessee 1,090 0 914 0 447 0 386 0 519 0 179.4 867.1
Texas 6,181 4 5,364 3 2,675 2 2,197 1 2,996 2 264.1 1,229.3
Utah 831 0 709 0 358 0 309 0 416 0 322.2 1,446.3
Vermont 180 0 149 0 65 0 58 0 76 0 290.0 1,451.8
Virgin Islands, U.S. ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Virginia 4,367 2 3,772 2 1,598 0 1,282 0 1,675 0 571.6 2,687.3
Washington 2,382 1 2,062 1 996 0 809 0 1,082 0 373.7 1,802.8
West Virginia 261 0 221 0 94 0 83 0 107 0 144.3 744.6
Wisconsin 1,483 0 1,289 0 535 0 429 0 557 0 266.1 1,314.6
Wyoming 63 0 59 0 32 0 26 0 39 0 122.9 628.0
Non U.S. resident 1,736 0 1,500 0 725 0 583 0 784 0 ††
Total 138,198 6,612 115,875 5,518 50,571 2,270 41,343 1,846 54,656 2,415 462.6 2,197.9
 * In cases of missing residency data, the patient’s state of residency was assigned as the state in which the ART procedure was performed. Numbers of procedures with missing 
residence are counted with the totals and separately displayed beside each count.
 † Source of population size: July 1, 2006 state population estimates. Population Division, U.S. Census Bureau, NST-EST 2007.
 § Of all ART procedures, 0.6% were reported from military medical centers located in California, District of Columbia, Hawaii, and Texas. States and territories for which >1% of 
ART procedures among state residents were performed in a military medical center were Alaska, Delaware, District of Columbia, Hawaii, Maryland, New Mexico, North Carolina, 
Oklahoma, Texas, Virginia, and Wyoming. In the District of Columbia and Hawaii, >5% of ART procedures among residents were performed in a military medical center. 
 ¶ Data not provided to preserve confidentiality but included in totals.
 ** Outcomes for New York do not include New York City, but denominator used to derive ratio of ART procedures started by population and women (15-44) includes New York City.
 †† Non-U.S. residents excluded because the appropriate denominators were unknown.
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TABLE 3. Percentage distribution of selected patient and treatment factors for assisted reproductive technology (ART) transfer 




n = 35,800 
(%)
35–37 
n = 19,184 
(%)
38–40 
n = 15,267 
(%)
41–42 
n = 6,676 
(%)
>42 




   Tubal factor 10.4 12.0 9.8 6.7 5.9
   Ovulation disorders 9.8 5.9 3.4 2.6 2.0
   Diminished ovarian reserve 2.4 5.1 11.8 22.0 31.9
   Endometriosis 6.6 5.7 4.0 2.2 1.2
   Uterine factor 1.0 1.4 2.0 1.9 1.4
   Male factor 24.7 19.7 14.9 9.1 5.3
   Other causes 6.3 7.6 9.3 10.0 11.2
   Unexplained cause 12.0 14.2 13.2 11.2 7.1
   Multiple factors, female only 8.8 10.8 12.6 15.7 15.1
   Multiple factors, female and male 18.0 17.6 19.0 18.5 18.8
Number of previous ART procedures
   0 65.7 55.2 50.4 46.7 41.9
   ≥1 34.3 44.8 49.6 53.3 58.1
Number of previous births
   0 78.2 67.3 65.5 63.1 63.0
   ≥1 21.8 32.7 34.5 36.9 37.0
Treatment factors
Method of embryo fertilization and transfer*
IVF-ET without ICSI 27.4 29.5 29.9 31.4 28.9
IVF-ET with ICSI 72.5 70.2 69.9 68.2 70.3
   IVF-ET with ICSI among couples diagnosed with  
    male factor infertility
39.8 34.3 30.9 24.5 21.2
   IVF-ET with ICSI among couples NOT diagnosed  
    with male factor infertility
32.7 35.9 39.0 43.7 49.1
GIFT 0.0 0.0 0.1 0.0 0.1
ZIFT 0.1 0.1 0.2 0.3 0.3
Combination 0.0 0.0 0.0 0.0 0.4
No. of days of embryo culture†
   1 0.2 0.2 0.2 0.4 0.4
   2 3.7 3.7 4.9 5.9 8.0
   3 58.1 64.4 68.2 71.8 73.9
   4 2.9 3.5 4.2 4.2 4.9
   5 32.5 25.9 20.5 16.0 11.7
   6 2.4 2.1 1.9 1.4 0.8
   ≥7 0.1 0.2 0.1 0.2 0.1
Number of embryos transferred
   1 8.7 10.1 11.9 15.5 19.9
   2 61.8 44.2 27.8 20.8 20.4
   3 23.4 33.3 33.4 23.2 20.5
   4 4.8 9.9 19.5 21.4 16.0
   ≥5 1.2 2.5 7.5 19.1 23.1
Extra embryo(s) available and cryopreserved
   No 54.2 67.0 79.5 90.3 95.4
   Yes 45.8 33.0 20.5 9.7 4.6
Use of gestational carrier
   No 99.1 98.8 98.9 98.7 98.9
   Yes 0.9 1.2 1.1 1.3 1.1
* IVF-ET = in vitro fertilization with transcervical embryo transfer; ICSI = intracytoplasmic sperm injection; GIFT = gamete intrafallopian transfer; ZIFT = 
zygote intrafallopian transfer; and Combination = a combination of IVF with or without ICSI and either GIFT or ZIFT.
† In cases of GIFT, gametes were not cultured but were transferred on day 1.
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TABLE 4. Percentages of transfers resulting in live births for assisted reproductive technology (ART) procedures performed 
among patients who used fresh embryos from their own eggs, by age group and selected patient or treatment factors — United 
States, 2006














    Tubal factor 43.3* 36.5* 25.3* 15.0* 5.5
    Ovulation dysfunction 46.7 41.0 31.1 22.3 5.8
    Diminished ovarian reserve 37.6 29.2 22.4 15.4 6.6
    Endometriosis 44.7 39.0 27.4 13.5 4.9
    Uterine Factor 43.5 36.1 29.3 12.6 10.4
    Male Factor 47.4 40.1 28.5 15.9 10.6
    Other causes 44.5 35.1 27.0 18.1 5.5
    Unexplained causes 45.4 38.5 31.0 17.0 7.9
    Multiple factors, female only 38.3 34.3 24.1 11.7 5.3
    Multiple Factors, female and  male 44.2 36.0 26.0 13.7 7.1
No. previous ART procedures
    0 46.7* 38.4* 27.5* 15.6 6.4
    ≥1 40.7 35.5 25.9 14.6 6.8
No. previous births
    0 43.6* 35.5* 25.2* 14.1* 6.5
    ≥1 48.4 40.3 29.5 16.7 6.8
Treatment factors
Method of fertilization and transfer†
    IVF-ET without ICSI 46.9* 39.3* 29.9* 16.4 7.7*
    IVF-ET with ICSI among couples diagnosed with  
      male factor infertility
45.8 38.2 27.1 14.5 8.1
    IVF-ET with ICSI among couples not diagnosed with  
      male factor infertility
41.5 34.2 24.0 14.5 5.4
No. of days of embryo culture§
    3 42.0* 35.2* 25.0* 14.3* 6.6
    5 51.8 43.8 35.3 21.7 9.1
No. of embryos transferred
    1 30.6* 20.0* 11.2* 5.2* 1.9*
    2 48.6 39.7 27.3 12.0 6.2
    3 41.6 39.4 29.0 15.7 6.6
    4 37.6 36.5 30.8 20.0 8.2
    >5 33.3 32.8 28.1 20.1 10.0
Extra embryos available and cryopreserved
    No 37.6* 32.1* 23.5* 13.6* 6.2*
    Yes 53.0 47.1 39.0 28.4 15.6
Use of gestational carrier
    No 44.6 37.0 26.6 15.0 6.6
    Yes 47.5 40.4 29.5 17.9 7.9
Total transfers resulting in live birth 44.7 37.1 26.7 15.1 6.6
* P<0.05, chi-square  to test for variations in live-birth rates across patient and treatment factor categories within each age group.
† IVF-ET = in vitro fertilization with transcervical embryo transfer, and ICSI = intracytoplasmic sperm injection. ART procedures including gamete intrafallopian 
transfer (GIFT), zygote intrafallopian transfer (ZIFT), and a combination of IVF with or without ICSI and either GIFT or ZIFT were not included because 
each of these accounted for a small proportion of procedures.
§ Limited to 3 and 5 days to embryo culture. ART procedures including 1, 2, 4, 6 and >7 days to embryo culture were not included because each of these 
accounted for a limited proportion of procedures.
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TABLE 5. Percentages of transfers resulting in live births for assisted reproductive technology (ART) procedures 
performed among patients who used donor eggs, by age group — United States, 2006
ART Procedure Type
Age Group (yrs)
































 Fresh Donor Eggs  
  (N=10,984)
1,187 54.4 1,184 54.3 1,722 55.2 1,717 52.4 4,239 53.2
Procedures Using 
 Thawed Donor Eggs  
  or Embryos (N=5,992)
611 34.9 585 32.7 867 33.0 819 31.6 2,574 31.1
Total (N=16,976) 1,798 47.8 1,769 47.2 2,589 47.8 2,536 45.7 6,813 44.8








Infants born in multiple-birth 
deliveries
No. (%)* No. (%)
Patient’s eggs used
Fresh embryos All ages 28,404 8,722 30.7 37,610 17,928 47.7
<35 15,990 5,507 34.4 21,799 11,316 51.9
35-37 7,113 2,120 29.8 9,357 4,364 46.6
38-40 4,072 919 22.6 5,043 1,890 37.5
41-42 1,005 155 15.4 1,165 315 27.0
 >42 224 21 9.4 246 43 17.5
Thawed embryos All ages 5,797 1,402 24.2 7,276 2,881 39.6
<35 3,350 881 26.3 4,276 1,807 42.3
35-37 1,468 330 22.5 1,819 681 37.4
38-40 697 129 18.5 833 265 31.8
41-42 197 46 23.4 247 96 38.9
 >42 85 16 18.8 101 32 31.7
Donor’s eggs used†
Fresh embryos All ages 5,393 2,107 39.1 7,572 4,286 56.6
Thawed embryos All ages 1,749 423 24.2 2,198 872 39.7
Total All ages 41,343 12,654 30.6 54,656 25,967 47.5
* Multiple birth risk
† Age-specific statistics are not presented for procedures that used donor eggs because only limited variation by age exists among these procedures.
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TABLE 7. Percentages of transfers resulting in live births and percentages of singletons, twins, and triplets or higher-order 
multiples for assisted reproductive technology (ART) procedures performed among patients who used freshly fertilized embryos 
from their own eggs, by patient’s age group, numbers of embryos transferred and embryo availability — United States, 2006
All ART transfer procedures
ART transfer procedures for women known to have 
































1 3,113 30.6 98.6 1.3 0.1 1,115 48.5 98.7 1.1 0.2
2 22,136 48.6 64.7 34.5 0.8 12,236 54.5 61.3 37.7 0.9
3 8,392 41.6 60.5 33.9 5.6 2,628 49.6 54.1 38.2 7.7
4 1,733 37.6 61.7 32.5 5.8 342 43.9 53.3 40.0 6.7
>5 418 33.3 54.0 37.4 8.6 69 37.7 38.5 57.7 3.8
35–37
1 1,942 20.0 98.2 1.5 0.3 350 40.6 97.9 2.1 *
2 8,485 39.7 70.8 28.8 0.4 3,693 48.1 66.7 32.9 0.4
3 6,393 39.4 67.0 29.3 3.7 1,873 46.6 62.3 33.9 3.8
4 1,891 36.5 65.7 30.6 3.8 359 47.6 62.6 30.4 7.0
>5 470 32.8 60.4 37.0 2.6 57 36.8 47.6 47.6 4.8
38–40
1 1,813 11.2 99.5 0.5 * 103 24.3 100.0 * *
2 4,236 27.3 81.6 18.1 0.3 1,129 40.4 74.6 24.8 0.7
3 5,094 29.0 75.0 23.6 1.4 1,212 38.7 70.8 27.1 2.1
4 2,978 30.8 73.8 23.9 2.3 559 40.6 66.5 31.3 2.2
>5 1,143 28.1 70.1 26.5 3.4 132 34.1 62.2 33.3 4.4
41–42
1 1,034 5.2 100.0 * * 22 13.6 100.0 * *
2 1,386 12.0 89.2 10.8 * 101 36.6 73.0 27.0 *
3 1,550 15.7 86.4 13.2 0.4 181 24.9 80.0 17.8 2.2
4 1,426 20.0 80.7 18.6 0.7 206 30.1 77.4 22.6 *
>5 1,278 20.1 80.9 17.9 1.2 139 26.6 73.0 27.0 *
>42
1 675 1.9 76.9 23.1 * 4 * * * *
2 692 6.2 97.7 2.3 * 30 16.7 80.0 20.0 *
3 694 6.6 95.7 4.3 * 33 15.2 80.0 20.0 *
4 540 8.1 90.9 6.8 2.3 40 20.0 87.5 12.5 *
>5 783 10.0 85.9 14.1 * 47 12.8 100.0 * *
* Statistics not provided for cases in which the denominator is <10.
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TABLE 8. Percentage of transfers resulting in live births and multiple-birth risk for assisted reproductive technology (ART) 
procedures using freshly fertilized embryos from the patient’s own eggs, by patient’s age group, number of embryos transferred, 
day of embryo transfer, and embryo availability — United States, 2006
Day 3* Day 5*
All ART transfer procedures
ART transfer procedures 
for women known to have 
more embryos available 
than transferred All ART transfer procedures
ART transfer procedures 
for women known to have 












































1 1,390 23.5 1.2 286 40.9 † 1,235 43.0 1.5 746 53.1 1.5
2 11,492 45.0 30.3 5,753 50.6 33.5 8,828 54.7 41.2 5,597 58.6 43.8
3 6,267 41.8 39.4 1,960 49.7 45.8 1,328 43.2 42.3 454 50.2 48.2
4 1,310 38.4 39.6 253 44.3 50.0 198 37.4 36.5 46 45.7 33.3
≥5 325 33.5 43.1 55 36.4 60.0 42 35.7 46.7 7 57.1 50.0
35-37
1 1,011 14.5 0.7 70 31.4 † 605 31.2 2.1 258 44.6 2.6
2 4,404 34.8 24.4 1,566 43.7 27.3 3,318 46.7 35.4 1,918 51.7 37.9
3 4,998 39.4 32.1 1,458 45.9 36.9 866 42.1 39.2 292 50.3 38.8
4 1,555 35.9 34.5 286 47.9 38.7 141 42.6 38.3 35 51.4 33.3
≥5 381 34.6 38.6 52 38.5 55.0 39 33.3 38.5 2 † †
38-40
1 1,032 9.3 1.0 14 21.4 † 406 18.5 † 77 27.3 †
2 2,197 20.5 14.2 402 33.6 20.7 1,514 39.7 22.6 657 45.1 28.4
3 3,711 27.5 23.0 864 35.9 28.1 906 36.3 30.1 270 47.8 33.3
4 2,516 30.4 26.1 464 39.4 33.3 209 34.4 27.8 47 51.1 25.0
≥5 951 28.6 27.9 110 32.7 30.6 87 29.9 42.3 12 41.7 80.0
41-42
1 616 3.9 † 1 † † 201 10.4 † 13 23.1 †
2 851 9.3 6.3 23 17.4 50.0 337 21.1 18.3 69 43.5 26.7
3 1,086 12.5 8.8 101 18.8 10.5 306 27.5 22.6 68 35.3 29.2
4 1,159 20.0 18.1 168 28.0 23.4 141 26.2 21.6 26 42.3 9.1
≥5 1,079 20.0 18.5 120 29.2 25.7 81 23.5 31.6 7 28.6 50.0
>42
1 430 0.9 25.0 0 † † 106 3.8 25.0 4 † †
2 473 5.1 † 7 14.3 † 97 15.5 6.7 19 21.1 25.0
3 512 6.1 6.5 18 16.7 33.3 84 9.5 † 11 9.1 †
4 431 7.4 3.1 32 12.5 † 53 11.3 33.3 5 40.0 †
≥5 655 11.1 13.7 41 14.6 † 56 5.4 † 2 † †
* The number of days the embryos were cultured.
† Statistics are not provided in cases where the denominator is <10.
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TABLE 9. Number and percentage of infants born in multiple-birth deliveries by patient’s state/territory of residence* at time of 
assisted reproductive technology (ART) procedure — United States, 2006
No. Infants born
Infants born in multiple-birth 
deliveries




Infants born in 
twin deliveries
(%)
Infants born in 
triplet or higher 
order deliveries
(%)
Patient’s state of 
residency No.
No. with missing 
residency No.
No. with missing 
residency
Alabama 369 0 174 0 47.2 42.3 4.9
Alaska 73 0 35 0 47.9 43.8 4.1
Arizona 890 2 411 2 46.2 40.1 6.1
Arkansas 203 0 120 0 59.1 53.2 5.9
California 7,288 359 3,553 155 48.8 44.0 4.7
Colorado 1,025 3 525 0 51.2 47.6 3.6
Connecticut 1,303 9 551 2 42.3 39.3 3.0
Delaware 138 0 63 0 45.7 41.3 4.3
District of Columbia§ 288 0 130 0 45.1 43.1 2.1
Federated States  
  of Micronesia
¶ ¶ ¶ ¶ ¶ ¶ ¶
Florida 2,505 4 1,225 0 48.9 44.4 4.6
Georgia 1,317 589 639 301 48.5 44.3 4.2
Guam ¶ ¶ ¶ ¶ ¶ ¶ ††
Hawaii 198 0 104 0 52.5 48.5 4.0
Idaho 232 0 111 0 47.8 40.5 7.3
Illinois 3,297 10 1,505 8 45.6 41.7 3.9
Indiana 630 0 303 0 48.1 41.0 7.1
Iowa 437 0 187 0 42.8 40.0 2.7
Kansas 295 0 126 0 42.7 38.6 4.1
Kentucky 425 0 215 0 50.6 43.8 6.8
Louisiana 343 0 183 0 53.4 44.3 9.0
Maine 128 0 79 0 61.7 50.0 11.7
Maryland 1,798 18 795 4 44.2 40.9 3.3
Massachusetts 2,965 893 1,212 402 40.9 39.4 1.5
Michigan 1,390 0 700 0 50.4 43.6 6.8
Minnesota 947 1 435 0 45.9 45.3 0.6
Mississippi 178 0 83 0 46.6 43.8 2.8
Missouri 795 1 395 0 49.7 42.8 6.9
Montana 109 0 55 0 50.5 47.7 2.8
Nebraska 243 0 123 0 50.6 45.7 4.9
Nevada 563 0 296 0 52.6 46.2 6.4
New Hampshire 304 0 134 0 44.1 42.1 2.0
New Jersey 3,622 93 1,811 48 50.0 46.0 4.0
New Mexico 163 0 93 0 57.1 47.9 9.2
New York** 4,419 29 1,959 12 44.3 40.5 3.8
New York City 1,383 217 612 91 44.3 42.7 1.5
North Carolina 1,179 1 564 0 47.8 43.5 4.3
North Dakota 91 0 50 0 54.9 48.4 6.6
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TABLE 9. (Continued) Number and percentage of infants born in multiple-birth deliveries by patient’s state/territory of residence* 
at time of assisted reproductive technology (ART) procedure — United States, 2006
No. Infants born
Infants born in multiple-birth 
deliveries




Infants born in 
twin deliveries
(%)
Infants born in 
triplet or higher 
order deliveries
(%)
Patient’s state of 
residency No.
No. with missing 
residency No.
No. with missing 
residency
Ohio 1,373 0 663 0 48.3 42.0 6.3
Oklahoma 321 0 153 0 47.7 44.9 2.8
Oregon 558 1 304 0 54.5 50.7 3.8
Pennsylvania 1,643 183 715 90 43.5 40.5 3.0
Puerto Rico 95 0 53 0 55.8 48.4 7.4
Rhode Island 272 0 119 0 43.8 39.3 4.4
South Carolina 516 0 267 0 51.7 48.8 2.9
South Dakota 85 0 40 0 47.1 40.0 7.1
Tennessee 519 0 255 0 49.1 42.8 6.4
Texas 2,996 2 1,554 2 51.9 47.0 4.9
Utah 416 0 217 0 52.2 51.4 0.7
Vermont 76 0 35 0 46.1 42.1 3.9
Virgin Islands, U.S. 5 0 4 0 80.0 80.0 0.0
Virginia 1,675 0 778 0 46.4 44.5 2.0
Washington 1,082 0 534 0 49.4 45.7 3.6
West Virginia 107 0 47 0 43.9 41.1 2.8
Wisconsin 557 0 253 0 45.4 43.8 1.6
Wyoming 39 0 25 0 64.1 56.4 7.7
Non U.S. resident 784 0 393 0 50.1 46.3 3.8
Total 54,656 2,415 25,967 1,117 47.5 43.4 4.1
 * In cases of missing residency data, that place where ART was performed is used for patient’s place of residency.
 † Statistics might not sum to total because of rounding.
 § Of all ART procedures, 0.6% were reported from military medical centers located in California, District of Columbia, Hawaii, and Texas. States and ter-
ritories for which >1% of ART procedures among state residents were performed in a military medical center were Alaska, Delaware, District of Columbia, 
Hawaii,  Maryland, New Mexico, North Carolina, Oklahoma, Texas, Virginia, and Wyoming.  In the District of Columbia, and Hawaii, >5% of ART procedures 
among residents were performed in a military medical center. 
 ¶ Data not shown to preserve confidentiality, but included in total.
 ** Outcomes for New York do not include New York City, but denominator used to derive ratio of ART procedures started by population and women (15-44) 
includes New York City.
TABLE 10. Contribution of assisted reproductive technology (ART) to the total number of infants born in 2006, by plurality — 
United States
ART infants*† U.S.-born infants§
Contribution of 
ART to the total 
number  of U.S.—
born infants
Plurality No. % of total No. % of total (%)
Infants born in singleton deliveries 27,031 51.2 4,121,930 96.6 0.7
Infants born in multiple-birth deliveries 25,761 48.8 143,625 3.4 17.9
Twins 23,284 44.1 137,085 3.2 17.0
Triplets or higher order 2,477 4.7 6,540 0.2 37.9
Total no. infants 52,792 4,265,555 1.2
* Source: Assisted Reproductive Technology Surveillance System.
† Includes infants conceived from ART procedures performed in 2005 and born in 2006, and infants conceived from ART procedures performed in 2006 and 
born in 2006.
¶ Source: U.S. natality file, CDC, National Center for Health Statistics. Please note that singleton deliveries reported by the U.S natality file include infants 
from singleton gestation and  multiple gestations.
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TABLE 11. Percentage of adverse perinatal outcomes* among assisted reproductive technology (ART) infants† born in 2006, by 




















ART singletons (n = 27,031) 9.3 1.9 14.3 6.9 1.9 2.4 0.1
ART twins (n = 23,284) 56.9 8.5 65.0 48.1 8.4 8.8 0.1
ART triplets or higher-order multiples (n = 2,477) 95.8 34.3 97.3 94.3 34.1 1.6 0.3
Total (n = 52,792) 34.3 6.3 40.6 29.1 6.2 5.2 0.1
* LBW = low birthweight (<2,500 g); VLBW = very low birthweight (<1,500 g); preterm = gestational age <37 weeks; preterm LBW = gestational age <37 weeks 
and low birthweight (<2,500 g); and term LBW = gestational age ≥37 weeks and low birthweight (<2,500 g).
† Includes infants conceived from ART procedures performed in 2005 and born in 2006 and infants conceived from ART procedures performed in 2006 and born 
in 2006. Samples for calculations of percentages of outcomes were subtracted from totals because of missing values for birthweight and gestational age.
TABLE 12. Percentage of adverse perinatal outcomes* among assisted reproductive technology (ART) singleton infants born in 




















Freshly fertilized embryos, patient eggs (n = 18,603) 9.3¶ 1.9¶ 13.4¶ 6.7¶ 1.9¶ 2.7¶ 0.0
Maternal age group (Yrs)
  <35 10.0 2.1 13.8 7.0 2.0 3.0 0.1
  35 – 37 8.6 1.6 12.5 6.0 1.5 2.6 0.0
  38 – 40 8.7 1.9 13.4 6.8 2.0 2.0 0.0
  41 – 42 8.1 1.4 12.4 6.3 1.4 1.8 0.0
  >42 11.7 3.1 16.1 9.2 3.1 2.6 0.0
Number  of previous births
  0 10.0** 2.1 13.4 7.0** 2.0 2.9** 0.1
  1 7.4 1.4 12.7 5.6 1.4 1.8 0.0
  ≥2 9.2 1.8 14.9 6.6 1.7 2.6 0.1
Freshly fertilized embryos, donors eggs (n = 2,995) 12.0 2.6 17.0 9.3 2.5 2.7 0.1
Thawed embryos†† (n = 5,433) 7.6 1.5 15.9 6.3 1.5 1.3 0.0
 * LBW = low birthweight (<2,500 g); VLBW = very low birthweight (<1,500 g); preterm = gestational age <37 weeks; preterm LBW = gestational age 
<37 weeks and low birthweight (<2,500 g); and term LBW = gestational age ≥37 weeks and low birthweight (<2,500 g).
 † Includes infants conceived from ART procedures performed in 2005 and born in 2006 and infants conceived from ART procedures performed in 2006 
and born in 2006.  Analysis excludes 699 singletons (575 for missing birth weight, 108 for missing gestational age, and 16 for missing both).
 § chi-square tests not reported as cell sizes are too small.
 ¶ p<0.01; chi-square to test for variations in adverse perinatal outcomes across procedure types.
 ** p<0.01; chi-square to test for variations in adverse perinatal outcomes across maternal factor categories.
 †† Includes cycles in which thawed embryos were used from patient eggs and donor eggs.
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